Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths.
Navigating adjuvant therapy options in hepatocellular carcinoma
- Post author:
- Post published:July 16, 2024
- Post category:uncategorized